✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹305 Cr.
P/E
12.58
  • Chemkart India
  • Mukka Proteins
FAQs on Chemkart India Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Chemkart India is 12.93

Growth Table
  • Chemkart India Ltd.
  • Mukka Proteins
Balance Sheet
  • Chemkart India Ltd.
  • Mukka Proteins
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Chemkart India Ltd.
  • Mukka Proteins
Cash Flow
  • Chemkart India Ltd.
  • Mukka Proteins
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Chemkart India Ltd.
  • Mukka Proteins
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Chemkart India Ltd. Financials

Balance sheet of Chemkart India is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Chemkart India is decreasing.
Latest net debt of Chemkart India is ₹11.37 Crs as of Mar-25.
This is less than Mar-24 when it was ₹12.42 Crs.

Yes, profit is increasing.
The profit of Chemkart India is ₹24.27 Crs for Mar 2025, ₹14.52 Crs for Mar 2024 and ₹7.66 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Chemkart India latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech